Peginterferon Alfa-2A
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00008 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 40 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hepatitis B virus infection | KG + DL |
| 2 | hepatitis E virus infection | KG + DL |
| 3 | hepatitis A virus infection | KG + DL |
| 4 | hepatitis, viral, animal | KG + DL |
| 5 | Omsk hemorrhagic fever | KG + DL |
| 6 | Kyasanur forest disease | KG + DL |
| 7 | heart conduction disease | KG + DL |
| 8 | heart neoplasm | KG + DL |
| 9 | heart valve disease | KG + DL |
| 10 | congenital anomaly of ventricular septum | KG + DL |
| 11 | pericardium disease | KG + DL |
| 12 | heart aneurysm | KG + DL |
| 13 | cardiac anomalies-heterotaxy syndrome | KG + DL |
| 14 | carcinoid heart disease | KG + DL |
| 15 | myocardial rupture | KG + DL |
| 16 | cor biloculare | KG + DL |
| 17 | white forelock with malformations | KG + DL |
| 18 | microcephaly-cardiac defect-lung malsegmentation syndrome | KG + DL |
| 19 | patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome | KG + DL |
| 20 | cardiac ventricle disease | KG + DL |
| 21 | aortopulmonary window | KG + DL |
| 22 | cardiovascular disease | KG + DL |
| 23 | tarp syndrome | KG + DL |
| 24 | cardiac disease with cataract | KG + DL |
| 25 | myocardial disorder | KG + DL |
| 26 | hereditary thrombocytopenia with normal platelets | KG + DL |
| 27 | marcothrombocytopenia with mitral valve insufficiency | KG + DL |
| 28 | transient neonatal thrombocytopenia | KG + DL |
| 29 | dense granule disease | KG + DL |
| 30 | hepatopulmonary syndrome | KG + DL |
| 31 | early-onset familial noncirrhotic portal hypertension | KG + DL |
| 32 | idiopathic copper-associated cirrhosis | KG + DL |
| 33 | hepatoportal sclerosis | KG + DL |
| 34 | primitive portal vein thrombosis | KG + DL |
| 35 | thrombocytopenia | KG + DL |
| 36 | disorder of tyrosine metabolism | KG + DL |
| 37 | Ledderhose disease | KG + DL |
| 38 | teratogenic Pierre Robin syndrome | KG + DL |
| 39 | HIV infectious disease | KG + DL |
| 40 | hepatic porphyria | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.